Physitrack PLC — Transactions under Share Buy-back Programme
Physitrack PLC ("Physitrack" or the "Company") announces that, pursuant to the share buy-back programme announced on 21 July 2026, the Company has purchased its own ordinary shares on Nasdaq First North Growth Market Stockholm during the week of 7 September 2026 to 11 September 2026, as set out below.
Summary of transactions
| Period | Total shares repurchased during the week | Volume-weighted average price paid (SEK) | Total consideration paid (SEK) | Total shares held by the Company (treasury) following these transactions | Total outstanding shares in the Company | Treasury holding as % of issued share capital |
| 7 September 2026 - 11 September 2026 | 6,442 | SEK 8.4780 | SEK 54,615.10 | 33,033 | 16,260,766 | 0.2031% |
Individual transactions
| Date | Quantity | Average price (SEK) |
| 2026-09-07 | 1,750 | 8.6743 |
| 2026-09-08 | 1,500 | 8.4733 |
| 2026-09-09 | 692 | 8.3600 |
| 2026-09-10 | 1,500 | 8.4000 |
| 2026-09-11 | 1,000 | 8.3400 |
The share buy-back programme is conducted within the safe harbour of Article 5 of the Market Abuse Regulation (EU) No 596/2014 ("MAR") and Commission Delegated Regulation (EU) 2016/1052, for the purpose of meeting the Company's obligations under its employee share plans. The programme is executed by Pareto Securities on a non-discretionary basis on Nasdaq First North Growth Market Stockholm.
Notification details
| 1. Issuer | Physitrack PLC, LEI 213800PC4QYNWHPCP774 |
| 2. Instrument/ISIN | Ordinary shares / GB00BYX22590 |
| 3. Trading venue | Nasdaq First North Growth Market Stockholm (PTRK) |
| 4. Currency | SEK |
| 5. Purpose of buy-back | To meet the Company's obligations under its employee share plans (a permitted purpose under Article 5(2) of MAR) |
| 6. Executing broker | Pareto Securities (non-discretionary mandate) |
This information is disclosed pursuant to Article 5 of MAR and Commission Delegated Regulation (EU) 2016/1052.